Aventis Recombinant Insulin Plant, Frankfurt, Germany
Key Data:
Order year
April 2001
Project type
New Plant
Location
Frankfurt, Germany
Estimated investment
€150 million
Completion
Mid-2003
Key Players:
Sponsor
Aventis Pharma Germany, Pfizer, Diabel
Lead engineer / designer
Linde-KCA-Dresden
Validation
Linde-KCA-Dresden
Financing
Aventis Pharma Germany, Pfizer
Output Chemicals:
Type
Human recombinant insulin
